Ikaros Cancer Vaccines
Ikaros Cancer Vaccines

Papers Courtesy of Dr. Peoples

Access papers supplied by Dr. Peoples to include Phase I GP2 Clinical Trial Results (2010) and Phase II GP2 Clinical Trial Results presented at the 2013 ASCO Annual Meeting.

Phase 1 GP2 Clinical Trial (2010)

Phase I GP2
2010. Phase I GP2 clinical trial.pdf
Adobe Acrobat document [417.3 KB]

Phase II Trial GP2 Vaccine to Prevent Recurrence in High Risk Breast Cancer Patients—A Planned Interim Analysis.

Phase II GP2
2013.Phase II Trial GP2.pdf
Adobe Acrobat document [237.7 KB]

2015. Phase II Trial Clinical Results with E75. Breast Cancer Immunotherapy*

Breast Cancer Immunotherapy
2015 E75. Breast Cancer immunotherapy,Ma[...]
Adobe Acrobat document [139.6 KB]

2015. Phase II Trial Clinical Results with E75. Breast Cancer
Immunotherapy

2014 E75 Vaccine.pdf
Adobe Acrobat document [3.6 MB]
2015.Rethinking cancer vaccines to avoid[...]
Adobe Acrobat document [337.8 KB]

Recent Clinical trials results with cancer vaccines by other investigators research papers and abstracts.

Courtesy Professor Dr. John Delinassios
 

International Institute of Anticancer Research (IIAR)

 

Journals: Anticancer Research, In Vivo, Cancer Genomics & Proteomics

 

1st km Kapandritiou-Kalamou Rd, PO. Box 22, GR-19014, Kapandriti, Attiki, Greece

USA Branch: Anticancer Research USA, Inc., PO Box 280, Belmar, NJ 07719,

USA 229-505-2945 ext. 1 Fax:+30-22950-52945 ext. 2.E-mail:

 

Email: subscriptions@iiar-anticancer.org

Web: http://iiarjournals.org 

 

Feel free to look at all the available articles of Anticancer Research
located at:** http://ar.iiarjournals.org/search
 

(Click on the link, type “vaccine”  in the box: “Text, Abstract, Title”)


Cite the complete reference and Journal. The material is the property of
IIAR.

This article is property of  the journal Anticancer Research:

2015 ASCO Annual Meeting

Contact Us

Ikaros Cancer Vaccines
Tartan Lane 4062 
Houston, TX 77025

 

Email:  info@ikaroscancervaccines.com

Print Print | Sitemap
© Ikaros Cancer Vaccines